HIGHLIGHTS
- who: Nikolaos Tsaftaridis et al. from the School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece have published the paper: Relapse of Monoclonal Gammopathy of Renal Significance after mRNA COVID-19 Vaccination: A Case Report, in the Journal: Life 2023, 13, x FOR PEER REVIEW of /2023/
- what: The treatment approach should be directed against the pathologic clone, with the primary goal of preserving kidney function. This may be the main reason why there are no data regarding disease relapse following vaccination.
SUMMARY
The present case report is, to the knowledge . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.